BRUNELLI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 25.627
EU - Europa 24.832
AS - Asia 16.708
SA - Sud America 2.486
Continente sconosciuto - Info sul continente non disponibili 953
AF - Africa 572
OC - Oceania 49
Totale 71.227
Nazione #
US - Stati Uniti d'America 24.777
RU - Federazione Russa 9.435
SG - Singapore 6.382
CN - Cina 4.963
GB - Regno Unito 4.641
IT - Italia 3.416
BR - Brasile 1.948
HK - Hong Kong 1.519
VN - Vietnam 1.515
DE - Germania 1.437
SE - Svezia 1.436
FR - Francia 1.119
IE - Irlanda 1.114
FI - Finlandia 855
KR - Corea 546
CA - Canada 544
BD - Bangladesh 375
IN - India 281
NL - Olanda 270
UA - Ucraina 252
JP - Giappone 234
AR - Argentina 191
TR - Turchia 181
MX - Messico 166
ES - Italia 150
PL - Polonia 148
NG - Nigeria 126
BE - Belgio 119
ZA - Sudafrica 110
IQ - Iraq 106
ID - Indonesia 97
EC - Ecuador 85
AT - Austria 81
LT - Lituania 75
CO - Colombia 74
PK - Pakistan 64
TG - Togo 62
MA - Marocco 55
BJ - Benin 52
VE - Venezuela 52
CL - Cile 48
SA - Arabia Saudita 46
UZ - Uzbekistan 44
AU - Australia 42
CZ - Repubblica Ceca 40
PY - Paraguay 37
PH - Filippine 36
MY - Malesia 33
AE - Emirati Arabi Uniti 29
TN - Tunisia 29
EG - Egitto 27
JO - Giordania 27
KE - Kenya 27
IR - Iran 26
JM - Giamaica 26
AZ - Azerbaigian 25
PT - Portogallo 22
LV - Lettonia 21
CH - Svizzera 20
KZ - Kazakistan 20
DZ - Algeria 19
AL - Albania 18
CR - Costa Rica 18
PE - Perù 18
RO - Romania 17
RS - Serbia 17
IL - Israele 16
NP - Nepal 16
GR - Grecia 15
UY - Uruguay 15
BO - Bolivia 14
DK - Danimarca 14
HN - Honduras 14
PA - Panama 14
PS - Palestinian Territory 14
BG - Bulgaria 13
DO - Repubblica Dominicana 13
CI - Costa d'Avorio 12
SN - Senegal 12
HU - Ungheria 11
KG - Kirghizistan 10
LB - Libano 10
AM - Armenia 9
ET - Etiopia 9
HR - Croazia 9
LK - Sri Lanka 9
NO - Norvegia 9
BY - Bielorussia 8
EU - Europa 8
MD - Moldavia 8
OM - Oman 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
TW - Taiwan 8
CY - Cipro 7
GT - Guatemala 7
MT - Malta 7
NI - Nicaragua 7
PR - Porto Rico 7
SK - Slovacchia (Repubblica Slovacca) 7
Totale 70.141
Città #
Southend 3.738
Singapore 3.430
Moscow 3.169
Ashburn 3.029
Chandler 2.472
San Jose 2.302
Dallas 2.167
Hong Kong 1.492
Jacksonville 1.339
Dublin 1.100
Woodbridge 1.068
Beijing 1.008
Ann Arbor 960
Verona 915
The Dalles 759
New York 728
Council Bluffs 607
Los Angeles 594
Houston 514
Munich 487
Ho Chi Minh City 471
Lawrence 368
Princeton 367
Wilmington 346
Jinan 332
Hanoi 313
Helsinki 309
Nanjing 248
Buffalo 231
São Paulo 230
Shenyang 229
Santa Clara 228
Milan 226
Tokyo 217
Rome 208
Montréal 195
Mcallen 179
Columbus 176
Hebei 175
Tianjin 175
Orem 169
Redondo Beach 169
London 157
Montreal 155
Turku 146
Sindelfingen 134
Dearborn 131
Frankfurt am Main 127
Zhengzhou 127
Warsaw 120
Redmond 118
Seattle 116
Abuja 115
Brussels 113
Seoul 111
Ningbo 106
Denver 105
Guangzhou 105
Changsha 104
Bologna 100
Boardman 96
Brooklyn 96
Taizhou 94
Stockholm 93
Chennai 90
Haikou 88
Amsterdam 85
Atlanta 84
Toronto 83
Chicago 81
Nanchang 80
Mexico City 76
Redwood City 74
Hangzhou 72
Johannesburg 70
Taiyuan 70
Phoenix 68
San Francisco 68
Jiaxing 66
Lancaster 66
Rio de Janeiro 64
Lomé 61
Poplar 61
Haiphong 60
Da Nang 59
Dong Ket 57
Manchester 54
Cotonou 52
Norwalk 52
Boston 51
Madrid 51
Volga 47
Belo Horizonte 46
Nuremberg 46
Vienna 46
Washington 46
Jakarta 44
Baghdad 43
Paris 40
Shanghai 40
Totale 42.249
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 901
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 677
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 378
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 339
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 319
Una complessa valutazione della vitalità delle fratture in ambito forense 314
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 287
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 267
Schwannoma del rene 262
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 259
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 256
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 256
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 254
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 250
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 250
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 249
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 246
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 246
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 243
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 234
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 232
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 231
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 231
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 228
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 227
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 224
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 224
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 223
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 223
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 222
CD10 is expressed in a subset of chromophobe renal cell carcinomas 219
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 219
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 218
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 218
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 218
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 218
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 217
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 217
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 217
Chondroid syringoma with extensive ossification 217
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 216
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 215
Adenocarcinoma of the paraurethral glands: a case report 214
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 213
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 213
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 212
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 212
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 209
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 208
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 208
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 206
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 205
Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy 204
Liver Metastases From Renal Oncocytoma With Vascular Extension 204
Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer 203
Extended pelvic lymphadenectomy for prostate cancer: should the cloquet's nodes dissection be considered only an option? 203
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer 203
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 202
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 202
Urachal carcinoma: from gross specimen to morphologic, immunohistochemical, and molecular analysis 202
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 201
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 201
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 201
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 201
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 201
Donor-Transmitted Cancers in Transplanted Livers: Analysis of Clinical Outcomes 201
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 201
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 200
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 200
Is a Drain Needed after Robotic Radical Prostatectomy with or without Pelvic Lymph Node Dissection? Results of a Single-Center Randomized Clinical Trial 200
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 200
Accuracy of on-bench biopsies in the evaluation of the histological subtype, grade, and necrosis of renal tumours 199
Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials 199
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 198
Body Mass Index and prostatic-specific antigen are predictors of prostate cancer metastases in patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection 198
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 197
[Small cell carcinoma of the bladder. Report of 3 cases and review of the literature] 197
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 196
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 196
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 196
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 195
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 195
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 195
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 194
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas 193
Diagnostic concordance between whole slide imaging and conventional light microscopy in cytopathology: A systematic review 193
[Diagnostic and prognostic markers in renal tumors] 192
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 192
Cortical Expression of the Polysialylated Isoform of the Neural Cell Adhesion Molecule on Brain Tissue to Recognize Drug-Related Death: An Exploratory Analysis 192
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 191
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 191
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series 191
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 191
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 190
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 190
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 189
'Case of the Month' from the University of Verona, Italy-navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 189
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 188
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 188
Totale 22.922
Categoria #
all - tutte 244.105
article - articoli 222.878
book - libri 0
conference - conferenze 20.804
curatela - curatele 0
other - altro 423
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 488.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.743 0 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/202510.130 507 544 549 1.656 428 351 579 448 1.428 687 983 1.970
2025/202632.374 2.061 1.614 2.351 5.587 8.304 2.120 2.688 1.643 2.697 1.909 563 837
2026/2027648 491 157 0 0 0 0 0 0 0 0 0 0
Totale 71.227